AIDX — 20/20 BIOLABS INC
As of Q2 2026, 5 SEC-registered investment managers reported holding AIDX (20/20 BIOLABS INC) in their latest 13F filings, with a combined reported value of $47.08K across 85.66K shares. That is +249.0% by share count (+61.12K shares) versus the previous quarter, while reported value moved +2.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 3 opened new positions, 1 added to existing stakes, 1 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
AIDX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Geode Capital Management history | 49.14K | $27.01K | 0.00% | New |
| Citadel Advisors history | 23.20K | $12.76K | 0.00% | Add |
| Bank of America Corp history | 13.02K | $7.15K | 0.00% | New |
| Morgan Stanley history | 283 | $156 | 0.00% | New |
| UBS Group AG history | 3 | $2 | 0.00% | Reduce |
Q1 2026 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Citadel Advisors history | 16.23K | $30.51K | 0.00% | New |
| UBS Group AG history | 8.31K | $15.63K | 0.00% | New |
New Positions (Q2 2026)
- Geode Capital Management 49.14K sh · $27.01K
- Bank of America Corp 13.02K sh · $7.15K
- Morgan Stanley 283 sh · $156
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 5 funds)
| Fund | Q2 2026 | Q1 2026 |
|---|---|---|
| Geode Capital Management | 49.14K | — |
| Citadel Advisors | 23.20K | 16.23K |
| Bank of America Corp | 13.02K | — |
| Morgan Stanley | 283 | — |
| UBS Group AG | 3 | 8.31K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details